台華新材(603055.SH):抓緊推進新生產基地建設進度,爭取儘快全面投產
格隆匯7月21日丨台華新材(603055.SH)近期在接待機構投資者調研時表示,2023年,隨着社會經濟生活逐步迴歸正軌和GDP穩增長預期下,發展形勢逐漸向好。公司業績今年一季度環比來看在改善。公司將全力以赴推動公司各項生產經營工作,努力完成2023年各項生產經營任務,充分發揮產業鏈優勢,認真貫徹執行“常規產品保產能,差異化產品保效益”的經營策略,以市場和客户需求為導向,鞏固優勢市場,把握錦綸66紗線和再生錦綸紗等新興市場,進一步優化產品結構和核心客户結構。同時抓緊推進新生產基地建設進度,爭取儘快全面投產。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.